Diabetes drug shows promise for heart health in small study
NCT ID NCT03498001
First seen Feb 04, 2026 · Last updated Jun 11, 2026 · Updated 18 times
Summary
This study measured how GLP-1 agonist drugs (like liraglutide) change fat levels in the heart muscle of 42 adults with type 2 diabetes. Participants had an MRI scan before and after 6 months of treatment. The goal was to see if these drugs reduce heart fat, which may help prevent heart failure. The study was completed and focused on understanding the drug's effects, not on curing diabetes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE II DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chu Dijon Bourgogne
Dijon, 21000, France
Conditions
Explore the condition pages connected to this study.